0
Arcutis Biotherapeutics, Inc. Banner Image

Arcutis Biotherapeutics, Inc.

  • Ticker ARQT
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arcutis Biotherapeutics, Inc. Logo Image
  • 51-200 Employees
  • Based in Westlake Village, California
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets toMore solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis.
Arcutis Biotherapeutics, Inc.

Most Recent Responsibility Report

Arcutis Biotherapeutics, Inc.
MOST RECENT 2022 ESG Report

Arcutis Biotherapeutics, Inc. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.

Request Information
Our service enables potential investors to review the most recent and archived Arcutis Biotherapeutics, Inc. Sustainability Report, Arcutis Biotherapeutics, Inc. Corporate Social Responsibility Report, Arcutis Biotherapeutics, Inc. CSR Report, Arcutis Biotherapeutics, Inc. Corporate Responsibility, Arcutis Biotherapeutics, Inc. CR Report, Arcutis Biotherapeutics, Inc. Citizenship Report, Arcutis Biotherapeutics, Inc. ESG Report, and Arcutis Biotherapeutics, Inc. Environmental Report online.
Arcutis Biotherapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!